This paper examines the dual challenge facing genetically modified organisms (GMOs) in food production: demonstrable scientific safety and public perception management. While transgenic crops offer solutions to global food security as population approaches nine billion, they face significant regulatory scrutiny and consumer skepticism. The paper explores actual risks such as horizontal gene transfer, distinguishes them from perceived risks that drive consumer behavior, and reviews regulatory frameworks in the European Union and United States. It concludes that GMO advocates must address both objective safety concerns and subjective public perception through transparent communication and labeling policies.
Genetically modified foods have the potential to solve many of the issues present in feeding the world's population, especially as it grows to an estimated nine billion by the end of the century. The technologies can create crops that are able to resist certain insects and are more suitable to grow in less than ideal environmental conditions. However, there are both real and perceived risks associated with these technological developments. There appears to be a general perception of skepticism regarding the safety of gene technology, and fears of potential negative implications rest in the collective consciousness of the public. This analysis examines a few of the factors associated with the continued use and development of genetically modified foods.
Currently, transgenic crops or genetically modified organisms (GMOs) are among the most highly regulated foods in the world and cover a broad range of different products (DeFrancesco, 2013). Many of these products have been on the market for more than a decade and have been consumed by millions of people without any adverse effects being identified. There does not appear to be evidence of ill effects from products that have been around for some time. However, this does not exclude the possibility that effects are difficult to determine or that new product developments could carry different risks.
Furthermore, certain risks are relevant to the environment rather than to consumers. These environmental considerations must be weighed alongside human health concerns when evaluating the overall safety profile of GMO technologies.
One potential risk is the movement of genetic information from one organism to another that occurs outside the realm of normal reproduction. Horizontal gene transfer (HGT) refers to all forms of gene transfer that do not involve parent-to-offspring transfer (sexual or asexual) and it can occur either naturally or by human intervention (for example, gene technology, embryo rescue, in vitro fertilization, protoplast fusion, and self-cloning) (Keese, 2008). Due to these mechanisms, a gene that was designed to be used in a controlled situation, such as in a genetically engineered crop that cannot reproduce naturally, can be released into the environment and could have potential impacts upon natural systems.
However, these risks are generally considered negligible to human health and the environment (Keese, 2008). The scientific consensus suggests that while HGT presents a theoretical concern, empirical evidence does not support significant harm from current GMO applications.
Beyond the actual risks that might be inherent in the use of the technology, the perceived risks from the public are likely far greater. Despite the potential for innovative biotechnologies to meet the needs of the world's growing food demands, a considerable amount of perceived risk exists across many different civilizations. The fact that perceived risk is a highly significant factor in shaping consumer behavior is widely accepted, and this is significant because consumer GM food purchasing behavior has been tied to the effects of perceived risk (Cabuk & Tanrikulu, 2014).
This disconnect between objective safety and subjective perception represents a major obstacle to GMO adoption. Consumer skepticism, often rooted in unfamiliarity with genetic technology rather than documented harm, shapes marketplace dynamics and policy debates in ways that scientific evidence alone cannot overcome.
The European Union has placed many regulations on the use of GMOs, and many in the United States have called for similar measures. There is significant push in the US for these foods to be labeled so that consumers can use this information in their purchasing decisions. Labeling policies reflect a regulatory philosophy that prioritizes consumer choice and transparency, even when scientific evidence does not demonstrate a safety concern. These frameworks represent an attempt to address public perception by giving consumers agency over their food choices.
The challenges for GMOs will thus be twofold. First, they must demonstrate scientifically that there are no significant risks associated with their development. Then they will also have to communicate these findings to the public to address public perceptions of risk with the development of GMOs. Success requires not only robust safety data but also effective science communication strategies that acknowledge legitimate consumer concerns and build public trust through transparency and dialogue.
You’re 96% through this paper. Sign up to read the full paper.
Sign Up Now — Instant Access Already a member? Log inAlways verify citation format against your institution’s current style guide requirements.